Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Turn Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for inflammatory and immunological conditions, particularly in dermatologic and infectious diseases [1] Corporate Updates - The company announced corporate updates ahead of its participation in the 2026 J.P. Morgan Healthcare Conference scheduled for January 12–15, 2026, in San Francisco [1] Financial Updates - Financial updates were included in the announcement, although specific figures were not detailed in the provided content [1] Pipeline Updates - Turn Therapeutics will discuss its pipeline developments during investor and partner meetings at the upcoming conference [1]